GSK extends emerging markets business

GlaxoSmithKline continued its march into the emerging markets by taking a 9.9 per cent in a South Korean drugs group yesterday. Europe's largest pharmaceuticals company said that it had entered into a strategic alliance with Dong-A Pharmaceuticals, paying £73.9m for its stake in the company.

David Prosser: How to get Britain making things again

Outlook By going with the decidedly old Labour strategy of industrial interventionism over the past 18 months, Lord Mandelson left himself open to exactly the sort of accusations of statism that Ken Clarke, his opposite number, has thrown at him during this election campaign. To which the Business Secretary must now be tempted to reply: "But it's working."

Swine flu jabs boost GSK sales

Glaxosmithkline revealed a further boost from last year's swine flu crisis yesterday as it said H1N1 treatments helped first-quarter sales surge 13 per cent.

Swine flu helps GSK to 13% sales surge

Pharmaceuticals giant GlaxoSmithKline revealed a further boost from last year's swine flu crisis today as it said H1N1 treatments helped first quarter sales surge 13 per cent.

Pressure grows on Germany to back Greek bailout

German politicians came under pressure today to cast aside their doubts over a bailout for Greece, with markets increasingly alarmed that Athens may default on its debt and trigger a meltdown elsewhere in Europe.

GSK orders European staff not to fly

Drug-maker GlaxoSmithKline has ordered staff in Europe not to fly for at least a week following the disruption caused by the volcanic ash cloud.

Emerging nations 'will push drug spending above $1trn'

Global spending on pharmaceuticals is expected to break through the $1trillion (£650bn) barrier over the next five years as demand from emerging economies surges, research shows.

Mark Dampier: Jupiter's fund is on another planet

The Analyst

Andy McSmith: Brown will be fuming over Tory letter-writing campaign

The public is not much in the mood to take George Osborne's word that he can find the money he'll need

David Prosser: Big pharma bites tongue on healthcare

Outlook Why the eerie silence from Britain's biggest pharmaceutical companies? On Monday, after more than a year of horsetrading, the US House of Representatives finally approved President Barack Obama's healthcare reforms. Yet 48 hours later, Britain's three FTSE 100 pharma giants – GlaxoSmithKline, AstraZeneca and Shire – have still not told us what they think.

Scientists' financial conflicts of interest may skew drug debate

Correction: GlaxoSmithKline

More than nine out of 10 scientists who backed a drug at the centre of a safety scare had financial links to the pharmaceutical industry, a study has found.

GSK to face FDA meeting over Avandia safety record

The Food and Drug Administration (FDA) will hold a public meeting on the possible heart risks of GlaxoSmith-Kline's (GSK) diabetes treatment Avandia in July, the US regulator said yesterday, but it urged doctors to continue prescribing the drug until any new advice was issued.

380 jobs set to go at GlaxoSmithKline

Drugs giant GlaxoSmithKline is to cut up to a third of jobs at one of its UK research and development sites, it was learned today.

GSK scales back workforce in neuroscience research

The transformation of GlaxoSmithKline from a company relying on a handful of expensive treatments to one dependent on consumer healthcare and emerging markets took a further step yesterday as it announced plans to scrap part of its neuroscience programme, with the loss of hundreds of jobs in the UK.

Fears for 4,000 jobs as GlaxoSmithKline seeks more savings

Drugs giant GlaxoSmithKline added to job woes in the sector today as it upped cost saving targets amid fears it plans to axe 4,000 roles.

Latest stories from i100
Career Services

Day In a Page

A
Independent Travel
Pompeii, Capri & the Bay of Naples
Seven Cities of Italy
Burgundy, the River Rhone & Provence
Prague, Budapest and Vienna
Lake Garda
Minoan Crete and Santorini
Prices correct as of 15 May 2015
Greece debt crisis: What happened to democracy when it’s a case of 'Vote Yes or else'?

'The economic collapse has happened. What is at risk now is democracy...'

If it doesn’t work in Europe, how is it supposed to work in India or the Middle East, asks Robert Fisk
The science of swearing: What lies behind the use of four-letter words?

The science of swearing

What lies behind the use of four-letter words?
The Real Stories of Migrant Britain: Clive fled from Zimbabwe - now it won't have him back

The Real Stories of Migrant Britain

Clive fled from Zimbabwe - now it won’t have him back
Africa on the menu: Three foodie friends want to popularise dishes from the continent

Africa on the menu

Three foodie friends want to popularise dishes from the hot new continent
Donna Karan is stepping down after 30 years - so who will fill the DKNY creator's boots?

Who will fill Donna Karan's boots?

The designer is stepping down as Chief Designer of DKNY after 30 years. Alexander Fury looks back at the career of 'America's Chanel'
10 best statement lightbulbs

10 best statement lightbulbs

Dare to bare with some out-of-the-ordinary illumination
Wimbledon 2015: Heather Watson - 'I had Serena's poster on my wall – now I'm playing her'

Heather Watson: 'I had Serena's poster on my wall – now I'm playing her'

Briton pumped up for dream meeting with world No 1
Wimbledon 2015: Nick Bollettieri - It's time for big John Isner to produce the goods to go with his thumping serve

Nick Bollettieri's Wimbledon Files

It's time for big John Isner to produce the goods to go with his thumping serve
Dustin Brown: Who is the tennis player who knocked Rafael Nadal out of Wimbeldon 2015?

Dustin Brown

Who is the German player that knocked Nadal out of Wimbeldon 2015?
Ashes 2015: Damien Martyn - 'England are fired up again, just like in 2005...'

Damien Martyn: 'England are fired up again, just like in 2005...'

Australian veteran of that Ashes series, believes the hosts' may become unstoppable if they win the first Test
Tour de France 2015: Twins Simon and Adam Yates have a mountain to climb during Tour of duty

Twins have a mountain to climb during Tour of duty

Yates brothers will target the steepest sections in bid to win a stage in France
John Palmer: 'Goldfinger' of British crime was murdered, say police

Murder of the Brink’s-MAT mastermind

'Goldfinger' of British crime's life ended in a blaze of bullets, say police
Forget little green men - aliens will look like humans, says Cambridge University evolution expert

Forget little green men

Leading evolutionary biologist says aliens will look like humans
The Real Stories of Migrant Britain: An Algerian scientist adjusts to life working in a kebab shop

The Real Stories of Migrant Britain

An Algerian scientist struggles to adjust to her new life working in a Scottish kebab shop
Bodyworlds museum: Dr Gunther von Hagens has battled legal threats, Parkinson's disease, and the threat of bankruptcy

Dying dream of Doctor Death

Dr Gunther von Hagens has battled legal threats, Parkinson's disease, and the threat of bankruptcy